Updates in IDH-Wildtype Glioblastoma

被引：0

作者：

Jawad M. Melhem

Jay Detsky

Mary Jane Lim-Fat

James R. Perry

机构：

[1] Sunnybrook Health Sciences Centre,Division of Neurology, Department of Medicine, Faculty of Medicine

[2] University of Toronto,Department of Radiation Oncology

[3] Odette Cancer Centre,undefined

[4] Sunnybrook Health Sciences Centre,undefined

来源：

Neurotherapeutics | 2022年 / 19卷

关键词：

Glioblastoma; IDH-wildtype; Targeted therapy; Precision medicine; Clinical trials;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Glioblastoma is the most aggressive primary brain tumor with a poor prognosis. The 2021 WHO CNS5 classification has further stressed the importance of molecular signatures in diagnosis although therapeutic breakthroughs are still lacking. In this review article, updates on the current and novel therapies in IDH-wildtype GBM will be discussed.

引用

页码：1705 / 1723

页数：18

共 50 条

[41] Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
Wende, Tim
Kasper, Johannes
Prasse, Gordian
Glass, Aenne
Kriesen, Thomas
Freiman, Thomas M.
Meixensberger, Juergen
Henker, Christian
CANCERS, 2021, 13 (22)
[42] Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients
Taiichi Saito
Kazuhiko Sugiyama
Seiji Hama
Fumiyuki Yamasaki
Takeshi Takayasu
Ryo Nosaka
Yoshihiro Muragaki
Takakazu Kawamata
Kaoru Kurisu
Neurosurgical Review, 2018, 41 : 621 - 628
[43] Molecular profile of adult primary leptomeningeal gliomatosis aligns with glioblastoma, IDH-wildtype
Zhu, Yi
Carabenciov, Darin D.
Johnson, Derek R.
Trejo-Lopez, Jorge A.
Nguyen, Aivi T.
Raghunathan, Aditya
Lanzino, Giuseppe
Ida, Cristiane M.
Zepeda-Mendoza, Cinthya J.
Dasari, Surendra
Russler-Germain, Emilie
Dahiya, Sonika
Quezado, Martha
Aldape, Kenneth
Giannini, Caterina
BRAIN PATHOLOGY, 2024,
[44] Distribution and favorable prognostic implication of genomic EGFR alterations in IDH-wildtype glioblastoma
Higa, Nayuta
Akahane, Toshiaki
Hamada, Taiji
Yonezawa, Hajime
Uchida, Hiroyuki
Makino, Ryutaro
Watanabe, Shoji
Takajo, Tomoko
Yokoyama, Seiya
Kirishima, Mari
Matsuo, Kei
Fujio, Shingo
Hanaya, Ryosuke
Tanimoto, Akihide
Yoshimoto, Koji
CANCER MEDICINE, 2023, 12 (01): : 49 - 60
[45] Targeted anticonvulsive treatment of IDH-wildtype glioblastoma based on DNA methylation subclasses
Drexler, Richard
Goettsche, Jennifer
Sauvigny, Thomas
Schueller, Ulrich
Khatri, Robin
Hausmann, Fabian
Haenzelmann, Sonja
Huber, Tobias B.
Bonn, Stefan
Heiland, Dieter H.
Delev, Daniel
Venkataramani, Varun
Winkler, Frank
Weller, Johannes
Zeyen, Thomas
Herrlinger, Ulrich
Gempt, Jens
Ricklefs, Franz L.
Duehrsen, Lasse
NEURO-ONCOLOGY, 2023, 25 (05) : 1006 - 1008
[46] Initial Treatment of IDH-Wildtype Glioblastoma in Adults Older Than 70 Years
Bao, Ling
Pan, Zhenjiang
Wei, Shepeng
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
[47] Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma
Bu, Linghao
Hameed, N. U. Farrukh
Luo, Chen
Hong, Pengjie
Zhou, Xiaoyu
Wang, Shengzhou
Wu, Shuai
JOURNAL OF NEURO-ONCOLOGY, 2021, 152 (01) : 27 - 36
[48] Quantification of Target Volume Changes on Radiation Planning MRI in IDH-Wildtype Glioblastoma
Bell, J. B.
Rich, B. J.
Mihaylov, I. B.
Benjamin, C.
Mellon, E. A.
Abramowitz, M. C.
Azzam, G.
Ei, M. D. P. Guillermo Prieto
De la Fuente, M.
Butkus, M.
Diwanji, T., Jr.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E588 - E588
[49] A clinical evaluation of cystic features in patients with newly diagnosed glioblastoma with IDH-wildtype
Kim, Min Joo
Park, Jae -Sung
Jeun, Sin -Soo
Ahn, Stephen
CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 228
[50] Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma
Linghao Bu
N. U. Farrukh Hameed
Chen Luo
Pengjie Hong
Xiaoyu Zhou
Shengzhou Wang
Shuai Wu
Journal of Neuro-Oncology, 2021, 152 : 27 - 36

← 1 2 3 4 5 →